Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery

J F Matthias Bechtel1, Simone Mühlenbein, Wolfgang Eichler

  • 1Department of Cardiac and Thoracic Vascular Surgery, University of Luebeck, Luebeck, Germany.

Insights

Intraoperative leukocyte depletion (LD) during cardiopulmonary bypass (CPB) in cardiac surgery did not show clear benefits. While faster extubation occurred, there were no significant differences in mortality or major complications.

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Medical Technology

Background:

  • Cardiopulmonary bypass (CPB) triggers an inflammatory response, partly due to leukocyte activation.
  • The efficacy of intraoperative leukocyte depletion (LD) during CPB remains uncertain despite previous studies.

Purpose of the Study:

  • To evaluate the impact of intraoperative leukocyte depletion (LD) using filters during routine adult cardiac surgery with CPB.

Main Methods:

  • A retrospective study involving 532 adult patients undergoing cardiac surgery with CPB.
  • Leukocyte filters were used continuously in arterial and cardioplegia lines for 2.5 months; control groups were patients operated immediately before and after.

Main Results:

  • No significant differences in 30-day mortality, transfusion needs, or major morbidity between groups.
  • Patients undergoing LD showed a trend towards lower preoperative leukocyte counts but no difference postoperatively.
  • A significantly higher percentage of LD patients were extubated within 12 hours (69% vs. 60%).

Conclusions:

  • The strategy of continuous intraoperative leukocyte depletion (LD) plus cardioplegia filtration during adult cardiac surgery with CPB did not demonstrate a clear clinical benefit.
  • Further research may be needed to determine optimal LD strategies or patient populations that could benefit.
Abstract